Cross-Species Translation and Target-Dependent Pharmacology of GalNAc-siRNAs Using a Multi-Parameter K-PD Framework for Biophase Kinetics, Apparent Potency, and Pharmacodynamic Turnover
Drug Design, Development and Therapy · 2026
DOI: 10.2147/dddt.s638364 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026. Verfasst von Xiaofei Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology Research Center, Beijing Key Laboratory of Key Technologies for Early Clinical Trial Evaluation of Innovative Drugs for Major D…. Hauptthemen laut MEDLINE: Acetylgalactosamine, RNA, Small Interfering, Models, Biological. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Pharmacology Research Center, Beijing Key Laboratory of Key Technologies for Early Clinical Trial Evaluation of Innovative Drugs for Major Diseases, Peking Union Medical College Hospital, Chinese Academy of Med…
- School of Clinical Pharmacy, Shenyang Pharmaceutical University, Shenyang, People's Republic of China.
ORCID-Profile: Xiaofei Wu, Jiahua Ma, Hongyun Wang
Zitieren
APA
Wu, X., Peng, X., Jia, R., Ma, J., Wang, H., & Han, X. (2026). Cross-Species Translation and Target-Dependent Pharmacology of GalNAc-siRNAs Using a Multi-Parameter K-PD Framework for Biophase Kinetics, Apparent Potency, and Pharmacodynamic Turnover. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s638364
Vancouver
Wu X, Peng X, Jia R, Ma J, Wang H, Han X. Cross-Species Translation and Target-Dependent Pharmacology of GalNAc-siRNAs Using a Multi-Parameter K-PD Framework for Biophase Kinetics, Apparent Potency, and Pharmacodynamic Turnover. Drug Design, Development and Therapy. 2026. doi:10.2147/dddt.s638364
BibTeX
@article{Wu2026,
author = {Wu, Xiaofei and Peng, Xuanji and Jia, Ranran and Ma, Jiahua and Wang, Hongyun and Han, Xiaohong},
title = {Cross-Species Translation and Target-Dependent Pharmacology of GalNAc-siRNAs Using a Multi-Parameter K-PD Framework for Biophase Kinetics, Apparent Potency, and Pharmacodynamic Turnover},
journal = {Drug Design, Development and Therapy},
year = {2026},
doi = {10.2147/dddt.s638364}
}
EUVIMED